Conformational analysis of prostaglandins F1 based on proton nuclear magnetic resonance spectral data. 1977

P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF

Related Publications

P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
February 1997, Journal of medicinal chemistry,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
May 1982, Biochemistry,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
December 1972, The Journal of biological chemistry,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
December 1979, Biochemistry,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
January 1970, Journal of the American Chemical Society,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
January 1974, Biochimie,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
December 1969, Proceedings of the National Academy of Sciences of the United States of America,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
June 2010, Analytical biochemistry,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
May 1974, The Journal of organic chemistry,
P De Clercq, and M Samson, and D Tavernier, and D Van Haver, and M Vandewalle
January 1989, Methods in enzymology,
Copied contents to your clipboard!